Pay in 4 interest-free payments of $6.96 Learn more
Ships within 48 hours · Estimated delivery Aug 23 - Aug 28
The program provides a year of free Noom or substantial medication discounts to anyone who regains the weight within 18 months following a 12-month course of Noom GLP-1Rx, including Nooms taper protocol
Dual Receptor Agonism: Tirzepatide acts as a dual agonist of the glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) receptors
Zepbound Self-Pay Journey Program For patients without insurance coverage, Lilly offers Zepbound in single-dose vial format through LillyDirect at reduced pricing
Obesity update: cardiovascular risk and therapeutic innovations (focus on semaglutide and tirzepatide)
Peer-reviewed research cited on this page reflects population-level or review-level findings and does not predict individual outcomes
They launched last month so theyve been out for a few weeks by now
